News

Filter

Current filters:

Levodopa

1 to 9 of 176 results

Although levodopa remains mainstay of Parkinson's, physicians will increasingly use other agents to delay need for the drug, says DR

13-05-2010

While levodopa remains the gold standard for Parkinson's disease treatment, physicians say they will…

LevodopaMarkets & MarketingNeurologicalPharmaceutical

Santhera closes Juvantia acquisition and final upfront payment from Biovail

05-10-2009

Switzerland’s Santhera Pharmaceuticals, which is focused on orphan neuromuscular diseases, has announced…

DoparEuropeLevodopaNeurologicalNorth AmericaPharmaceutical

Santhera buys Juvantia to get rights to Parkinson’s drug fipamezole

17-08-2009

Swiss biotechnology firm Santhera Pharmaceuticals has entered into an agreement to gain rights to JP-1730/fipamezole…

DoparEuropeLevodopaNeurologicalPharmaceutical

Safinamide enters Ph III SETTLE trial

11-05-2009

Germany's Merck KGaA and Italian drugmaker Newron Pharmaceuticals have initiated the SETTLE study, a…

DopamineDopamine HydrochlorideDoparLevodopaMerck KGaA

Impax updates on lead candidates

21-04-2009

Impax Pharmaceuticals, the brand products division of Impax Laboratories, has commenced a Phase III trial…

CarbidopaDoparLevodopaLodosyn

1 to 9 of 176 results

Back to top